The Food and Drug Administration (FDA) on Thursday approved the first drug for use in imaging abnorm...
In response to the unfolding COVID-19 public health crisis, federal agencies have announced new chan...
The FDA on Tuesday issued an updated warning that constipation caused by the antipsychotic clozapine...
FDA Program for Reducing Unsafe Opioid Prescribing and Adverse Events Fails to Produce Clear Results
It is unclear whether the government’s strategy for reducing unsafe opioid prescribing and adverse e...
The Food and Drug Administration (FDA) this week approved Caplyta (lumateperone), an oral atypical a...
On Friday, the Food and Drug Administration (FDA) announced that it is permitting the marketing of t...
